The aim of SKINAID is to communicate the latest in skin science to the broadest audience

Vision

We look at the world of skin through data; with facts and evidence rather than opinion as our guiding star. There is public appetite for science news; we believe that information and data available in Peer Review journals or scientific publications should reach a wider audience instead of just the happy few. We also want to reach busy physicians, journalists, consumers and patients.

We believe that a greater level of evidence will improve outcomes, enhance knowledge and boost consumer / patient trust and confidence.

Why?

Skin is fascinating! Beyond being the largest organ, the skin is the silent mirror of important systemic disorders (compromised skin) and the reflection of external concerns (healthy skin and ageing skin). The study of skin spans various disciplines: hard science (scientific and medical), soft science (philosophy, sociology, anthropology…). Last but not least the skin plays a critical role in the on-going digital revolution: artificial intelligence, machine learning, Internet of Things, wearable tech, Tech tattoos, 3D printing, Virtual Reality, quantified self, quantified skin…

What?

There are the five overarching themes and questions which drive our daily quest for information and dissemination:

  1. today’s paradigm is provided by randomized clinical trials and their publications in scientific or medical journals. Where will credibility come from tomorrow? Big data, social networks embracing medicine, patients’ social media post analysis, long term data registries…
  2. how will digital technologies enable pharmaceutical and consumer brands to engage with patients and consumers on a daily basis, about medicine in general, and dermatology and skincare in particular?
  3. why does consumer access remains so low? The current level of scientific evidence is quite poor, but what would be considered as an adequate level of evidence? How can a superior consumer experience be created? How should the scientific evidence be communicated to the end user?
  4. Why will “connected beauty” disrupt these categories? How will legislation evolve to regulate advertising claims? How can industry respond to growing skincare needs such as skin and health, ageing prevention, sensitive skin or the role of microbiome and nutrition?
  5. According to the World Health Organisation both non-melanoma and melanoma skin cancers have been increasing over the past decades; we are now facing an epidemic of these conditions. How did we get to this stage? Various initiatives including the ABCDE of melanoma have been developed by prestigious institutions to improve awareness and diagnosis but there is still no improvement in the prevalence of melanoma. Why is prevention apparently not effective and how hopeful does the future look?

Who?

The SKINAID collaborative web site is curated by Mr Dominique du Crest with input from a variety of skin expert contributors.

Following 13 years at L’Oréal and 12 years with Grey Healthcare, Dominique du Crest founded SKINAID, a media and consulting company focused on dermatology, aesthetic dermatology, cosmetics and At-home beauty devices.

Dominique is an active member of the Home Use Device (HUD) Working Group, a member of the European Academy of Dermatology and Venerology (EADV) and a faculty member of the International Master Course on Aging Skin (IMCAS). Dominique is responsible for the IMCAS Cosmeceuticals Master Class and he is also the Executive Editor of the IMCAS Academy. He receives an honorarium for his work with IMCAS.

Internal rules

None of SKINAID posts are sponsored. In the future the financial model will come from content syndication, cross-sectional surveys, cohort studies and a subtle dose of online advertising.

Consulting

We work with organisations and individuals whose activities relate to skin. We understand skin science in its broadest sense. We offer assistance to imagine and create unique differentiators and superior value. We enable companies to communicate more effectively with the relevant targets.